Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Pater

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 31, 1998
Does a visible retinal embolus increase the likelihood of hemodynamically significant carotid artery stenosis in patients with acute retinal arterial occlusion?S Sharma, G C Brown, J L Pater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG)S F Dent, D Klaassen, J L Pater, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 1, 1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapyD Osoba, C Erlichman, A R Willan, et al.
The Annals of Pharmacotherapy|April 1, 1997
Extent and variation of omeprazole prescribing in an elderly population of OntarioJ E McBride, J L Pater, J L Dorland, et al.
Journal of the National Cancer Institute|October 19, 1988
Trimetrexate: predictors of severe or life-threatening toxic effectsE A Eisenhauer, B C Zee, J L Pater, et al.
Investigational New Drugs|August 1, 1990
Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group studyE A Eisenhauer, K I Pritchard, D J Perrault, et al.
The Canadian Journal of Oncology|February 1, 1996
The role of palliative radiotherapy for brain metastasesL Paszat, G Shenouda, P Blood, et al.
Journal of Clinical Apheresis|January 1, 1984
A controlled trial of plasma exchange in rheumatoid arthritisA R Giles, I L Dwosh, P M Ford, et al.
The New England Journal of Medicine|May 12, 1983
Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trialI L Dwosh, A R Giles, P M Ford, et al.
Archives of Internal Medicine|July 1, 1992
A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic eventsR B Haynes, R S Sandler, E B Larson, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 31, 1998
Does a visible retinal embolus increase the likelihood of hemodynamically significant carotid artery stenosis in patients with acute retinal arterial occlusion?S Sharma, G C Brown, J L Pater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG)S F Dent, D Klaassen, J L Pater, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 1, 1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapyD Osoba, C Erlichman, A R Willan, et al.
The Annals of Pharmacotherapy|April 1, 1997
Extent and variation of omeprazole prescribing in an elderly population of OntarioJ E McBride, J L Pater, J L Dorland, et al.
Journal of the National Cancer Institute|October 19, 1988
Trimetrexate: predictors of severe or life-threatening toxic effectsE A Eisenhauer, B C Zee, J L Pater, et al.
Investigational New Drugs|August 1, 1990
Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group studyE A Eisenhauer, K I Pritchard, D J Perrault, et al.
The Canadian Journal of Oncology|February 1, 1996
The role of palliative radiotherapy for brain metastasesL Paszat, G Shenouda, P Blood, et al.
Journal of Clinical Apheresis|January 1, 1984
A controlled trial of plasma exchange in rheumatoid arthritisA R Giles, I L Dwosh, P M Ford, et al.
The New England Journal of Medicine|May 12, 1983
Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trialI L Dwosh, A R Giles, P M Ford, et al.
Archives of Internal Medicine|July 1, 1992
A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic eventsR B Haynes, R S Sandler, E B Larson, et al.
Pageof 7